BC
ALBO

Burney Company’s Albireo Pharma Inc ALBO Stock Holding History

Burney Company’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,976
Closed -$238K – 586
2022
Q1 		$238K Buy
+7,976
New +$234K 0.01% 534
2021
Q4 		– Sell
-7,976
Closed -$249K – 601
2021
Q3 		$249K Hold
7,976
– – 0.01% 518
2021
Q2 		$281K Buy
7,976
+900
+13% +$29.3K 0.01% 510
2021
Q1 		$249K Buy
7,076
+1,000
+16% +$36.9K 0.01% 509
2020
Q4 		$228K Buy
+6,076
New +$221K 0.01% 484

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Burney Company's ALBO Position: Q2 2022 in Review

Burney Company sold out of Albireo Pharma Inc (ALBO) in Q2 2022, closing a stake of 7,976 shares — an estimated $238K sold.

Burney Company first reported a position in ALBO in Q4 2020 and held it in 5 quarters. The position peaked at $281K in Q2 2021. 103 funds tracked by Wall St. Rank hold ALBO as of Q2 2022.

  • Burney Company reported no remaining Albireo Pharma Inc position as of Q2 2022 after selling out during the quarter.
  • Burney Company sold 7,976 Albireo Pharma Inc shares in Q2 2022, an estimated $238K.
  • Burney Company first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 5 quarters.
  • Burney Company's Albireo Pharma Inc position peaked at $281K in Q2 2021.
  • 103 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2022.

Based on Burney Company's 13F filing for Q2 2022, filed 12 Aug 2022.